Literature DB >> 11413385

High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus.

Zhuhui Huang1, Sateesh Krishnamurthy1, Aruna Panda1, Siba K Samal1.   

Abstract

A previous report showed that insertion of a foreign gene encoding chloramphenicol acetyltransferase (CAT) between the HN and L genes of the full-length cDNA of a virulent Newcastle disease virus (NDV) yielded virus with growth retardation and attenuation. The NDV vector used in that study was pathogenic to chickens; it is therefore not suitable for use as a vaccine vector. In the present study, an avirulent NDV vector was generated and its potential to express CAT protein was evaluated. The CAT gene was under the control of NDV transcriptional start and stop signals and was inserted immediately before the open reading frame of the viral 3'-proximal nucleocapsid protein gene. A recombinant NDV expressing CAT activity at a high level was recovered. The replication and pathogenesis of the CAT-expressing recombinant NDV were not modified significantly. These results indicate the potential utility of an avirulent NDV as a vaccine vector.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413385     DOI: 10.1099/0022-1317-82-7-1729

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

1.  Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.

Authors:  Sunil K Khattar; Senthilkumar Palaniyandi; Sweety Samal; Celia C LaBranche; David C Montefiori; Xiaoping Zhu; Siba K Samal
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice.

Authors:  Xinxin Chen; Jifei Yang; Yanhong Ji; Edward Okoth; Bin Liu; Xiaoyang Li; Hong Yin; Qiyun Zhu
Journal:  Virol Sin       Date:  2016-03-11       Impact factor: 4.327

4.  Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.

Authors:  Ekaterina G Viktorova; Sunil K Khattar; Diana Kouiavskaia; Majid Laassri; Tatiana Zagorodnyaya; Eugenia Dragunsky; Siba Samal; Konstantin Chumakov; George A Belov
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

5.  Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice.

Authors:  Shin-Hee Kim; Shun Chen; Xi Jiang; Kim Y Green; Siba K Samal
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

6.  Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.

Authors:  Shin-Hee Kim; Madhuri Subbiah; Arthur S Samuel; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

7.  Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs.

Authors:  Sunil K Khattar; Sweety Samal; Anthony L Devico; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

8.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  The large polymerase protein is associated with the virulence of Newcastle disease virus.

Authors:  Subrat N Rout; Siba K Samal
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

10.  Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.

Authors:  Baibaswata Nayak; Subrat N Rout; Sachin Kumar; Mohammed S Khalil; Moustafa M Fouda; Luay E Ahmed; Kenneth C Earhart; Daniel R Perez; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.